Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingfang Granules for air-conditioning-related common cold
ChiCTR2000036543Phase 4Not yet recruiting
- Sponsor
- Zhangjiagang Hospital of Traditional Chinese Medicine
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Jingfang Granules in nasopharyngitis and upper respiratory infection (URI) (2 arms), sponsored by Zhangjiagang Hospital of Traditional Chinese Medicine. Primary endpoint: Recovery rate on the 3rd day of treatment. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
Jingfang Granules
03
Conditions
nasopharyngitisupper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2000036543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036543.